Status:
COMPLETED
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
South-Eastern Norway Regional Health Authority
Norwegian Health Association
Conditions:
Heart Transplant Recipients
Physical Fitness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Compared to end-stage heart failure, a patient's situation is usually greatly improved after a heart transplant (HTx), but the exercise capacity remains sub-normal, also long-term, ranging from 50 to ...
Eligibility Criteria
Inclusion
- Clinically stable HTx recipients approximately 8-12 weeks after HTx.
- Age \> 18 years, both sexes
- Received immunosuppressive therapy as per local protocol.
- Patient willing and capable of giving written informed consent for study participation and anticipated to be able to participate in the study for 9- 12 months.
Exclusion
- Unstable condition or postoperative complications
- Recent severe rejection episodes
- Physical disabilities which prevent participation
- Other diseases or disabilities that contradict/refrain from exercise.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01796379
Start Date
February 1 2013
End Date
December 5 2019
Last Update
December 9 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital
Copenhagen, Denmark
2
Oslo University Hospital Rikshospitalet
Oslo, Norway, 0424
3
Sahlgrenska University Hospital
Gothenburg, Sweden